Optimizing Immunotherapy Combined With Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

NCT07040098 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

228

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer (LARC)

Interventions

DRUG: Sintilimab
RADIATION: Short-course radiotherapy
RADIATION: Long-course concurrent chemoradiotherapy
COMBINATION_PRODUCT: CAPOX

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences